Pityriasis rubra pilaris following booster dose of mRNA (Pfizer-BioNTech) COVID-19 vaccine

Hlača, Nika; Žagar, Tina; Kaštelan, Marija; Peternel, Sandra; Brajac, Ines; Dujmović-Hasanbegović, Katarina; Prpić-Massari, Larisa

doi:10.1111/dth.15791

Pregled bibliografske jedinice broj: 1210912

Pityriasis rubra pilaris following booster dose of mRNA (Pfizer- BioNTech) COVID-19 vaccine

Hlača, Nika; Žagar, Tina; Kaštelan, Marija; Peternel, Sandra; Brajac, Ines; Dujmović-Hasanbegović, Katarina; Prpić-Massari, Larisa

Pityriasis rubra pilaris following booster dose of mRNA (Pfizer- BioNTech) COVID-19 vaccine // Dermatologic therapy, 35 (2022), 11; e15791, 2 doi:10.1111/dth.15791 (međunarodna recenzija, članak, stručni)

CROSBI ID: 1210912 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Pityriasis rubra pilaris following booster dose of mRNA (Pfizer- BioNTech) COVID-19 vaccine

Autori
Hlača, Nika ; Žagar, Tina ; Kaštelan, Marija ; Peternel, Sandra ; Brajac, Ines ; Dujmović-Hasanbegović, Katarina ; Prpić-Massari, Larisa

Izvornik
Dermatologic therapy (1396-0296) 35 (2022), 11; E15791, 2

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni

Ključne riječi
Adverse reaction ; COVID-19 Vaccines ; COVID-19 vaccine booster shot ; Pityriasis Rubra Pilaris ; SARS-CoV-2

Sažetak
Data on various cutaneous adverse events as a result of widespread SARS-CoV-2 vaccination is currently accumulating. However, data on cutaneous reactions following booster dose of COVID-19 vaccines are still limited.1, 2 Herein, we present a case of pityriasis rubra pilaris (PRP) following a booster dose of the BNT163b2 (Pfizer–BioNTech) mRNA COVID-19 vaccine.

Izvorni jezik
Engleski

POVEZANOST RADA

Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Rijeka,
Sveučilište u Rijeci

Profili:

Larisa Prpić Massari (autor)